Spire Healthcare GroupCHIX:SPIL -2.53%75 Return-on-Tangible-Asset is 1.03% as of Dec. 2025, which is 56% above its 10-year median of 0.66. GuruFocus rates CHIX:SPIL with a GF Score™ of 75/100 and a GF Value™ of £2.71 (Modestly Undervalued). The stock has 7 warning signs investors should review. Among 683 Healthcare Providers & Services companies, Spire Healthcare Group ranks worse than 58.42% on this metric.
Return-on-Tangible-Asset is calculated as Net Income divided by its average total tangible assets. Total tangible assets equals to Total Assets minus Intangible Assets. Spire Healthcare Group's annualizedNet Income for the quarter that ended in Dec. 2025 was £20 Mil. Spire Healthcare Group's average total tangible assets for the quarter that ended in Dec. 2025 was £1,928 Mil. Therefore, Spire Healthcare Group's annualized Return-on-Tangible-Asset for the quarter that ended in Dec. 2025 was 1.03%.
The historical rank and industry rank for Spire Healthcare Group's Return-on-Tangible-Asset or its related term are showing as below:
CHIX:SPIl'
s Return-on-Tangible-Asset Range Over the Past 10 Years
Min: -13.15 Med: 0.66 Max: 4.57
Current: 0.85
During the past 13 years, Spire Healthcare Group's highest Return-on-Tangible-Asset was 4.57%. The lowest was -13.15%. And the median was 0.66%.
CHIX:SPIl's Return-on-Tangible-Asset is ranked worse than 58.42% of 683
companies
in the Healthcare Providers & Services industry
Industry Median: 2.43
vs CHIX:SPIl: 0.85
Spire Healthcare Group (CHIX:SPIl) Return-on-Tangible-Asset Explanation
Return-on-Tangible-Asset measures the rate of return on the average total tangible assets (total assets minus intangible assets). Tangible means physical in nature. Intangible Assets are assets that are not physical in nature, and typically "derive their value from legal or intellectual rights." Return-on-Tangible-Asset measures a firm's efficiency at generating profits from its tangible assets. It shows how well a company uses what it has to generate earnings. Return-on-Tangible-Assets can vary drastically across industries. Therefore, Return-on-Tangible-Asset should not be used to compare companies in different industries.
Be Aware
Like ROE and ROA, Return-on-Tangible-Asset is calculated with only 12 months data. Fluctuations in the companys earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective. Return-on-Tangible-Asset can be affected by events such as stock buyback or issuance, and by a companys tax rate and its interest payment. Return-on-Tangible-Asset may not reflect the true earning power of the assets. A more accurate measurement is ROC % (ROC).
Many analysts argue the higher return the better. Buffett states that really high Return-on-Tangible-Asset may indicate vulnerability in the durability of the competitive advantage.
Spire Healthcare Group Return-on-Tangible-Asset Related Terms
Spire Healthcare Group Return-on-Tangible-Asset Historical Data
* Premium members only.
The historical data trend for Spire Healthcare Group's Return-on-Tangible-Asset can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Spire Healthcare Group Return-on-Tangible-Asset Chart
CHIX:SPIL vs HCA, THC, DVA: Return-on-Tangible-Asset Comparison
For the Medical Care Facilities subindustry, Spire Healthcare Group's Return-on-Tangible-Asset, along with its competitors' market caps and Return-on-Tangible-Asset data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Spire Healthcare Group Return-on-Tangible-Asset vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Spire Healthcare Group's Return-on-Tangible-Asset distribution charts can be found below:
* The bar in red indicates where Spire Healthcare Group's Return-on-Tangible-Asset falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual Return-on-Tangible-Asset, the net income of the last fiscal year and the average total tangible assets over the fiscal year are used. In calculating the quarterly data,
the Net Income data used here is two times the semi-annual (Dec. 2025) net income data.
What does a Return-on-Tangible-Asset of 1.03% mean?
Spire Healthcare Group (CHIX:SPIL) has a Return-on-Tangible-Asset of 1.03% as of Dec. 2025. Return on tangible assets is the ratio of current-period net income to average two-period tangible assets. View historical data on Spire Healthcare Group and its competitors. This is 56% above median its historical median of 0.66. According to the industry distribution chart, Spire Healthcare Group ranks #399 out of 683 companies in the Healthcare Providers & Services industry, placing it in the top 58.4%.
Is Spire Healthcare Group's Return-on-Tangible-Asset too high?
Spire Healthcare Group's current Return-on-Tangible-Asset of 1.03% is 56% above median its 10-year median of 0.66. The Healthcare Providers & Services industry median Return-on-Tangible-Asset is 2.43. Spire Healthcare Group's value of 1.03% is 57.6% below this industry median. Based on the distribution chart, Spire Healthcare Group ranks #399 out of 683 companies in the Healthcare Providers & Services industry, which is below the industry midpoint. Overall, Spire Healthcare Group has a GF Score™ of 75/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Spire Healthcare Group's Return-on-Tangible-Asset compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Spire Healthcare Group ranks #399 out of 683 companies for Return-on-Tangible-Asset. This places Spire Healthcare Group in the lower half of its industry. The industry median Return-on-Tangible-Asset is 2.43. Spire Healthcare Group's value of 1.03% is 57.6% below this benchmark. While the company's 10-year median is 0.66 vs. the industry median of 2.43, Spire Healthcare Group has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Return-on-Tangible-Asset for a Healthcare Providers & Services company?
The median Return-on-Tangible-Asset among Healthcare Providers & Services companies is 2.43, based on 683 companies in the industry. Companies in the top quartile (top 25%) have a Return-on-Tangible-Asset significantly above this median, while those in the bottom quartile fall well below. However, Return-on-Tangible-Asset should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Spire Healthcare Group's current Return-on-Tangible-Asset of 1.03% is 57.6% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Return-on-Tangible-Asset mean?
A high Return-on-Tangible-Asset can signal that a stock is expensive relative to its fundamentals. Return on tangible assets is the ratio of current-period net income to average two-period tangible assets. View historical data on Spire Healthcare Group and its competitors. For the Healthcare Providers & Services industry, the median Return-on-Tangible-Asset is 2.43 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Spire Healthcare Group's current Return-on-Tangible-Asset is 1.03%, which is 56% above median its own 10-year median of 0.66. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Spire Healthcare Group stock overvalued right now?
Based on GuruFocus' analysis, Spire Healthcare Group (CHIX:SPIL) is currently considered Modestly Undervalued. The stock's GF Value™ is £2.71, compared to a current price of £2.12 — trading 22% below its estimated fair value. The current Return-on-Tangible-Asset is 1.03%, which is 56% above median its 10-year median of 0.66 and 57.6% below the Healthcare Providers & Services industry median of 2.43. Spire Healthcare Group's overall GF Score™ is 75/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Return-on-Tangible-Asset calculated?
Return-on-Tangible-Asset is calculated from a company's financial statements. For Spire Healthcare Group (CHIX:SPIL), the current Return-on-Tangible-Asset is 1.03% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Spire Healthcare Group (CHIX:SPIL) Overvalued in 2026?
Based on GuruFocus' analysis, Spire Healthcare Group stock appears to be undervalued.
The current stock price of £2.12 is trading 22% below its estimated GF Value™ of £2.71.
GuruFocus considers Spire Healthcare Group to be Modestly Undervalued.
Key valuation signals for CHIX:SPIL:
Return-on-Tangible-Asset: 1.03% (56% above median its 10-year median of 0.66)
GF Value™: £2.71 vs. price of £2.12 (22% below fair value)
Industry Position: 57.6% below the Healthcare Providers & Services median (#399 of 683)
No single metric tells the full story. See the CHIX:SPIL stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Spire Healthcare Group PLC is an independent hospital group in the United Kingdom. It is a private provider, by volume, of knee and hip operations in the United Kingdom. The company has two operating segments: the hospitals business and the Primary care. The company generates the majority of its revenue from Hospital Business, which consists of hospitals, clinics, medical centres and consulting rooms. The company provide diagnostics, inpatient, day case and outpatient care in areas including orthopaedics, gynaecology, cardiology, neurology, oncology and general surgery. The primary care segment encompasses services focused on the primary care needs of outpatients, including GP services, occupational health services or mental and physical health services.
75GF Score
Get the complete analysis for CHIX:SPIL
Return-on-Tangible-Asset is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
CHIX:SPIL has been successfully added to your 
